Dove anti-perspirant deodorant promoting the PitiCure
NEW YORK Unilever’s Dove anti-perspirant deodorant is promoting the PitiCure, a three-step process for the treatment of delicate underarm skin.
The PitiCure process includes:
- Underarm exfoliation: Use a gentle scrub or wipe to cleanse underarmsand help remove impurities.
- Rinse: Rinse off and gently dry underarms with a towel.
- Apply Dove Visibly Smooth anti-perspirant deodorant.
The brand is inviting beauty mavens to experience the PitiCure treatment for free at The PitiCure Pavilion. This pop-up spa will be in Los Angeles at The Grove from June 10 to 14; New York at South Street Seaport from June 24 to 28; and Philadelphia at King of Prussia Mass from July 8 to 11.
FDA announces voluntary recall of hand sanitizers
WASHINGTON The Food and Drug Administration has announced the voluntary recall of some skin sanitizers and skin protectants by Clarcon Biological Chemistry Laboratory Inc. because of bacterial contamination risk.
The products, which are marketed under several different brand names, are being recalled because high levels of disease-causing bacteria that were found in the products during a recent inspection. Some of these bacteria can cause opportunistic infections of the skin and underlying tissues. Such infections may need medical or surgical attention, and may result in permanent damage.
The FDA is warning consumers not to use any Clarcon product and to throw these products in the trash. The products that should be discarded include:
- Citrushield lotion
- Dermascentials DermaBarrier
- Dermassentials by Clarcon antimicrobial hand sanitizer
- Iron Fist Barrier hand treatment
- Skin Shield Restaurant
- Skin Shield Industrial
- Skin Shield Beauty Salon lotion
- Total Skin Care Beauty
- Total Skin Care Work
According to the FDA, the findings of its recent inspection of the Clarcon facility are particularly concerning because the products are promoted as antimicrobial agents that claim to treat open wounds, damaged skin and protect against various infectious diseases.
Reports: P&G to shift McDonald to CEO post
CINCINNATI Procter & Gamble is expected to appoint COO Robert McDonald as its next CEO, succeeding A.G. Lafley, according to a Wall Street Journal report.
Citing people familiar with the situation, the board is expected to approve on Tuesday the appointment of the former 29-year company veteran. While a P&G spokesperson declined to comment, sources told the WSJ that Lafley will remain chairman, and likely will play a hands-on role in managing the company.
The transition is expected to take place on July 1.
During his tenure at P&G, Lafley has revitalized the company and coordinated the $57 billion acquisition of Gillette Co., creating a consumer products powerhouse with more than 20 billion-dollar brands.
The recession has hampered P&G’s business as consumers are curbing spending, and in May, the company issued a lower-than-expected earnings forecast for fiscal 2010. But at least one source told the WSJ that Lafley’s departure has been in the works for at least two or three years and is not related to any dissatisfaction with his performance.
McDonald, a West Point graduate who served as a U.S. Army captain, joined P&G in 1980. He rose through the ranks quickly, managing such brands as Solo, Cascade, Tide and Dawn. In the 1990s, McDonald spent his time in Asia as P&G expanded its reach beyond North America. In 2004, he was appointed vice chairman global operations and has served as COO for the past two years.